Clinical Trials Sponsored by NovImmune SA

Total 1045 results

Biosensors Europe SA

Completed

Study to Evaluate the Safety and Effectiveness of the Biosensors Microcatheter in Coronary Chronic Total Occlusions (CTO) - BIOMICS (BIOMICS)

Ischemic Heart Disease

United Kingdom
Contrad Swiss SA

Completed

Evaluation of the Effect of the "CR500 SINGLE-DOSE GEL" Medical Device in Patients With Knee Osteoarthritis (KOA)

Knee Osteoarthritis

Italy
Quantum Genomics SA

Completed

Firibastat in Treatment-resistant Hypertension (FRESH)

Hypertension

United States, Czechia, France, Germany, Poland, Spain
Technophage, SA
VectorB2B

Completed

Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers (REVERSE)

Diabetic Foot Ulcer | Staphylococcus Aureus Infection | Pseudomonas Aeruginosa Infection | Acinetobacter Infection

Israel
Debiopharm International SA

Completed

A Dose-Finding Study of the Second Mitochondrial Activator of Caspases (SMAC) Mimetic Debio 1143 When Given in Combination With Avelumab to Participants With Advanced Solid Malignancies and to Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Platinum-Based Therapy

Neoplasms | Carcinoma, Non-Small-Cell Lung

Canada, Poland, Romania
AB Biotics, SA

Completed

Efficacy and Safety of a Probiotic Composition as Adjunct in MAFL Management

Non Alcoholic Fatty Liver

Mexico
AC Immune SA

Withdrawn

A Study of ACI-24 in Adults With Down Syndrome

Down Syndrome
AuXin Surgery SA

Completed

Usefulness of the CADISS® System for the Cleavage of Severe Adhesions in Cholecystectomy

Cholecystitis, Acute

Belgium
AuXin Surgery SA

Completed

Use of CADISS Medical Device to Facilitate Dissection of Epidural Fibrosis in Revision Spine Surgery

Spine Surgery

Belgium
Rhizen Pharmaceuticals SA

Completed

Efficacy and Safety of Tenalisib (RP6530) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Leukemia, Lymphocytic, Chronic, B-Cell

Georgia, Bulgaria, Poland
Med Discovery SA

Completed

PK, PD, Tolerability and Safety of MDPK67b in Healthy Volunteers

Prostatic Neoplasms

Switzerland
Biosensors Europe SA

Active, not recruiting

LEADERS FREE II: BioFreedom™ Pivotal Study

Acute Coronary Syndrome | High Bleeding Risk

United States, Canada, France, Italy, United Kingdom, Germany, Denmark
Naturex SA
BioFortis

Completed

A Clinical Trial to Evaluate the Chronic Safety and Tolerance of Turmipure Gold™ in Healthy Subjects (TURBIO-GOLD)

Liver Function | Gastrointestinal Tolerance | Kidney Function

France
MedDay Pharmaceuticals SA

Terminated

Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) (SPI2)

Multiple Sclerosis

United States, Spain, Canada, Australia, United Kingdom, Belgium, Turkey, Czechia, Poland, Italy, Hungary, Germany, Sweden
Medacta International SA

Completed

Pedicle Screw Positioning With MySpine vs Free Hand Technique

Spinal Deformity
AB Biotics, SA

Completed

Interventional Study to Evaluate the Effect of the Oral Administration of L.Plantarum on Vaginal Microbiota

Vaginal Infection

Spain
Biosensors Europe SA

Completed

BioFreedom Pharmacokinetic Study

Myocardial Infarction | Coronary Artery Disease

Spain
Chiesi SA/NV

Unknown

Adherence Evaluation in COPD

COPD | Adherence, Treatment

Belgium
Medacta International SA

Completed

Matched Pair Study - Kinematic vs Mechanical Alignment

Osteoarthritis, Knee | Joint Disease

Germany
Bio Sidus SA

Completed

Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers

Anemia
Rhizen Pharmaceuticals SA

Terminated

Safety and Efficacy Study of Tenalisib (RP6530) in Combination With Pembrolizumab in Relapsed or Refractory cHL

Classical Hodgkin Lymphoma

United States
Rhizen Pharmaceuticals SA

Terminated

Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Lymphomas

Lymphoma

United States, Australia
Regen Lab SA

Completed

Treatment of Keloid Scar by Autologous Platelet Rich Plasma Obtained With RgenKit-BCT

Keloid
Regen Lab SA

Unknown

Cellular Matrix Device for the Treatment of Mild to Moderate Knee Osteoarthritis

Knee Osteoarthritis

France
Debiopharm International SA

Completed

Study of Debio 1450 for Bacterial Skin Infections

Bacterial Infections

United States
Celyad Oncology SA

Withdrawn

EPITHINK: Epigenetic Drug Treatment and Therapeutic Immunotherapy With NKR-2 (EPITHINK)

Myelodysplastic Syndromes | AML, Adult
Biosensors Europe SA

Completed

e-BioMatrix Canada Registry

Device Related MACE and Bleeding

Canada
Biosensors Europe SA

Completed

e-BioMatrix PostMarket Registry (eBMX-PMR)

Coronary Artery Disease

United Kingdom, Spain, France, Ireland, Switzerland, Germany, Denmark, Austria, Latvia, Czechia, Jordan, Lithuania, Morocco, Poland, Portugal, Russian Federation
Biosensors Europe SA

Completed

e-BioMatrix PostMarket Surveillance Registry

Coronary Artery Disease

Switzerland, Spain, United Kingdom
Miracor Medical SA

Completed

PiCSO in ACS Study

Acute Coronary Syndrome

United Kingdom
Medacta International SA

Unknown

Understanding GMK Sphere Implant Tibiofemoral Kinematics by Means of Dynamic Videofluoroscopy

Arthroplasty | Replacement, Knee

Switzerland
Helsinn Healthcare SA

Terminated

Effects of Somnage® in the Management on Sleep and Mood in Cancer Patients

Breast Cancer | Lung Cancer | Colon Cancer

Italy
Rhizen Pharmaceuticals SA

Completed

To Evaluate the Food Effect on Relative Bioavailability of RP6530 in Healthy Volunteers

Healthy

Canada
MedDay Pharmaceuticals SA

Completed

MD1003-AMN MD1003 in Adrenomyeloneuropathy

Adrenoleukodystrophy | Adrenomyeloneuropathy | AMN

France, Germany, Spain
Helsinn Healthcare SA

Completed

Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA (MEI-005)

Myelodysplastic Syndrome | MDS

United States
Debiopharm International SA

Terminated

Alisporivir (Deb025) and Boceprevir Triple Therapies in African American Participants Not Previously Treated for Chronic Hepatitis C Genotype 1

Hepatitis C

United States
Quantum Genomics SA

Completed

Phase IIa Study of the Product QGC001 Compared With Placebo in Patients With Essential Hypertension (2QG1)

Essential Hypertension

France
Helsinn Healthcare SA

Withdrawn

Evaluation of the Effects of a Mixture of Amino Acids (Amixea) on Lean Body Mass and Muscle Strengh of Patients With Unresectable Advanced Non-small Cell Lung Cancer

Cancer Patients With Cachexia

Australia
Debiopharm International SA

Completed

Efficacy and Safety of Alisporivir Alone or Combined With RBV or PEG in Chronic Hepatitis C Genotype 2 and 3 Treatment-naïve Participants

Chronic Pain | Hepatitis C

United States, Belgium, Germany, Taiwan, Australia, France, Thailand, Puerto Rico, United Kingdom, Italy, India, Poland, Korea, Republic of, Canada
Celyad Oncology SA

Unknown

Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-2) Trial - THE CHART-2 TRIAL (CHART-2)

Heart Failure
Debiopharm International SA

Completed

Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients

Hepatitis C | Liver Disease

Germany, Sweden, United Kingdom, Poland
Rheon Medical SA

Unknown

Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device

Glaucoma

Switzerland
Debiopharm International SA

Completed

A Single Dose Study of Debio 1450 in Healthy Subjects

Bacterial Infections

United States
Air Liquide SA

Terminated

General Anesthesia With Xenon in Inspiratory Concentrations of 50% and 70% and Total I.V. Anaesthesia.

Anaesthesia

United Kingdom, France, Germany
Miracor Medical SA

Completed

PICSO in Patients With STEMI Treated by Primary Percutaneous Coronary Intervention (pRAMSES)

ST Elevation (STEMI) Myocardial Infarction

Netherlands
Helsinn Healthcare SA

Completed

Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea

Diarrhea

Russian Federation, Bulgaria, Hungary, Romania
Cerenis Therapeutics, SA

Completed

Exploratory Study of Plaque Regression (EXPRESS)

Heterozygous Familial Hypercholesterolemia

Canada
Air Liquide SA

Completed

NOWOX Oxygen Therapy Monitoring Device

Chronic Obstructive Pulmonary Disease

France
Fovea Pharmaceuticals SA

Completed

Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Fovea Pharmaceuticals SA

Terminated

Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion (FOV2302)

Central Retinal Vein Occlusion | Macular Edema

France

3

Subscribe